Status:
ENROLLING_BY_INVITATION
Gene Expression in Inflammatory Bowel Disease
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Inflammatory Bowel Disease
Eligibility:
All Genders
7+ years
Brief Summary
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by...
Detailed Description
Progress has been made in recent years in understanding the pathological mechanisms of IBD, particularly in the search of IBD susceptibility genes. However, due to the extreme complexity of the diseas...
Eligibility Criteria
Inclusion
- All persons, regardless of IBD affection status, greater than 7 years of age undergoing upper or lower endoscopy or bowel resection
Exclusion
- Persons with bleeding tendencies
- Persons on anti-coagulation therapy or who will be place on anti-coagulation therapy following the planned endoscopy procedures
Key Trial Info
Start Date :
November 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2032
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT01171872
Start Date
November 1 1999
End Date
December 1 2032
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21231